Humanigen, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

444863203
SEDOL

BM9GXF8
CIK

0001293310

www.humanigen.com
LEI:
New: Infographics X-Lab
FIGI: BBG005V4X9P2
HGEN

Humanigen, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
AI
PROFILER
NAME
Humanigen, Inc.
ISIN
US4448632038
TICKER
HGEN
MIC
XNAS
REUTERS
HGEN.OQ
BLOOMBERG
HGEN US
F&G: 30
5.505,35 S&P · 24,38 Vola-Index · 93.872,03 BTC · 1,13584 EURUSD
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
This section is currently still under construction. If you are interested in short-selling statistics, you can find out here, for example.
Click here for comprehensive price and chart analyses
smart.AD

Trading Solutions for Professionals

  • 25 kinds of clusters
  • 26 world exchanges
  • 14 different charts
  • 58 necessary for analysis indicators
  • 50+ customized templates for charts


Get your free Demo today

RNS News: Temporary or possibly permanent suspension of the stock exchange listing.

At the moment it is not possible to render the historical price development in the form of a chart. There may be various reasons for this, such as a delisting due to a takeover or stock market withdrawal. But don't worry: alternative sources for further research are available to you via the stock exchange symbol, TV icon or the button panel below the chart window. For delistings or ISIN/ticker changes, you may find what you are looking for here.

HGEN
The charts are provided by TradingView. Millions of investors use the innovative tools and solutions. If you are interested in professional tools, e.g. in the field of technical analysis, you are sure to find what you are looking for here.
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S